Sartorius Stedim Biotech SA logo

Sartorius Stedim Biotech SA

OTCPK:SDMHF (Germany)   Ordinary Shares
$ 224.44 0 (0%) 10:08 PM EST
61.99
P/B:
7.28
Market Cap:
$ 21.75B
Enterprise V:
$ 24.99B
Volume:
225.00
Avg Vol (2M):
208.00
Also Trade In:
Volume:
225.00
Avg Vol (2M):
208.00
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sartorius Stedim Biotech SA ( ) from 1990 to Apr 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sartorius Stedim Biotech stock (SDMHF) PE ratio as of Apr 28 2024 is 61.99. More Details

Sartorius Stedim Biotech SA (SDMHF) PE Ratio (TTM) Chart

To

Sartorius Stedim Biotech SA (SDMHF) PE Ratio (TTM) Historical Data

Total 1215
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Sartorius Stedim Biotech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-28 61.9 2024-02-23 73.3
2024-04-26 61.9 2024-02-22 73.3
2024-04-25 61.9 2024-02-21 73.3
2024-04-24 61.9 2024-02-20 72.4
2024-04-23 61.9 2024-02-16 72.4
2024-04-22 59.0 2024-02-15 72.4
2024-04-19 59.0 2024-02-14 70.4
2024-04-18 62.2 2024-02-13 70.0
2024-04-17 74.5 2024-02-12 74.9
2024-04-16 74.5 2024-02-09 74.9
2024-04-15 74.5 2024-02-08 70.9
2024-04-12 75.9 2024-02-07 70.9
2024-04-11 75.9 2024-02-06 70.9
2024-04-10 75.9 2024-02-05 72.3
2024-04-09 75.9 2024-02-02 72.3
2024-04-08 75.9 2024-02-01 73.0
2024-04-05 75.8 2024-01-31 71.4
2024-04-04 77.0 2024-01-30 71.4
2024-04-03 76.1 2024-01-29 71.5
2024-04-02 76.3 2024-01-26 71.5
2024-04-01 76.3 2024-01-25 68.9
2024-03-28 77.1 2024-01-24 66.4
2024-03-27 77.1 2024-01-23 66.4
2024-03-26 79.6 2024-01-22 66.4
2024-03-25 82.7 2024-01-19 66.8
2024-03-22 82.7 2024-01-18 66.8
2024-03-21 79.0 2024-01-17 66.8
2024-03-20 79.0 2024-01-16 67.8
2024-03-19 79.0 2024-01-12 70.1
2024-03-18 80.0 2024-01-11 70.1
2024-03-15 81.6 2024-01-10 72.0
2024-03-14 81.6 2024-01-09 72.9
2024-03-13 81.6 2024-01-08 72.9
2024-03-12 81.6 2024-01-05 72.9
2024-03-11 80.3 2024-01-04 72.9
2024-03-08 80.3 2024-01-03 73.5
2024-03-07 80.3 2024-01-02 72.8
2024-03-06 73.4 2023-12-29 72.8
2024-03-05 73.4 2023-12-28 73.0
2024-03-04 73.4 2023-12-27 49.5
2024-03-01 73.4 2023-12-26 51.2
2024-02-29 73.4 2023-12-22 51.2
2024-02-28 73.4 2023-12-21 51.2
2024-02-27 73.4 2023-12-20 51.2
2024-02-26 72.6 2023-12-19 47.9

Sartorius Stedim Biotech SA (SDMHF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.